vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and AMERICAN AXLE & MANUFACTURING HOLDINGS INC (AXL). Click either name above to swap in a different company.
AMERICAN AXLE & MANUFACTURING HOLDINGS INC is the larger business by last-quarter revenue ($1.4B vs $962.7M, roughly 1.4× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -5.4%, a 13.2% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 0.2%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $54.7M). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -7.2%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
American Axle & Manufacturing, Inc. (AAM), headquartered in Detroit, Michigan, is an American manufacturer of automobile driveline and drivetrain components and systems.
ATR vs AXL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $1.4B |
| Net Profit | $74.3M | $-75.3M |
| Gross Margin | — | 10.2% |
| Operating Margin | 11.0% | -2.4% |
| Net Margin | 7.7% | -5.4% |
| Revenue YoY | 13.5% | 0.2% |
| Net Profit YoY | -26.4% | -449.6% |
| EPS (diluted) | $1.13 | $-0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $1.4B | ||
| Q3 25 | $961.1M | $1.5B | ||
| Q2 25 | $966.0M | $1.5B | ||
| Q1 25 | $887.3M | $1.4B | ||
| Q4 24 | $848.1M | $1.4B | ||
| Q3 24 | $909.3M | $1.5B | ||
| Q2 24 | $910.1M | $1.6B | ||
| Q1 24 | $915.4M | $1.6B |
| Q4 25 | $74.3M | $-75.3M | ||
| Q3 25 | $127.9M | $9.2M | ||
| Q2 25 | $111.7M | $39.3M | ||
| Q1 25 | $78.8M | $7.1M | ||
| Q4 24 | $100.9M | $-13.7M | ||
| Q3 24 | $100.0M | $10.0M | ||
| Q2 24 | $90.5M | $18.2M | ||
| Q1 24 | $83.1M | $20.5M |
| Q4 25 | — | 10.2% | ||
| Q3 25 | — | 12.6% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 12.3% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | 13.3% | ||
| Q1 24 | — | 12.4% |
| Q4 25 | 11.0% | -2.4% | ||
| Q3 25 | 14.2% | 3.2% | ||
| Q2 25 | 14.9% | 3.6% | ||
| Q1 25 | 12.8% | 3.0% | ||
| Q4 24 | 14.2% | 2.6% | ||
| Q3 24 | 15.2% | 2.8% | ||
| Q2 24 | 13.8% | 5.3% | ||
| Q1 24 | 12.2% | 4.8% |
| Q4 25 | 7.7% | -5.4% | ||
| Q3 25 | 13.3% | 0.6% | ||
| Q2 25 | 11.6% | 2.6% | ||
| Q1 25 | 8.9% | 0.5% | ||
| Q4 24 | 11.9% | -1.0% | ||
| Q3 24 | 11.0% | 0.7% | ||
| Q2 24 | 9.9% | 1.1% | ||
| Q1 24 | 9.1% | 1.3% |
| Q4 25 | $1.13 | $-0.62 | ||
| Q3 25 | $1.92 | $0.07 | ||
| Q2 25 | $1.67 | $0.32 | ||
| Q1 25 | $1.17 | $0.06 | ||
| Q4 24 | $1.48 | $-0.11 | ||
| Q3 24 | $1.48 | $0.08 | ||
| Q2 24 | $1.34 | $0.15 | ||
| Q1 24 | $1.23 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $708.9M |
| Total DebtLower is stronger | $1.1B | $4.0B |
| Stockholders' EquityBook value | $2.7B | $640.0M |
| Total Assets | $5.3B | $6.7B |
| Debt / EquityLower = less leverage | 0.43× | 6.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $708.9M | ||
| Q3 25 | $264.8M | $714.1M | ||
| Q2 25 | $169.8M | $586.5M | ||
| Q1 25 | $136.8M | $549.2M | ||
| Q4 24 | $226.2M | $552.9M | ||
| Q3 24 | $327.9M | $542.5M | ||
| Q2 24 | $223.9M | $519.9M | ||
| Q1 24 | $201.1M | $469.8M |
| Q4 25 | $1.1B | $4.0B | ||
| Q3 25 | $546.0M | $2.6B | ||
| Q2 25 | $535.1M | $2.6B | ||
| Q1 25 | $561.2M | $2.6B | ||
| Q4 24 | $688.1M | $2.6B | ||
| Q3 24 | $822.7M | $2.6B | ||
| Q2 24 | $681.5M | $2.7B | ||
| Q1 24 | $680.4M | $2.7B |
| Q4 25 | $2.7B | $640.0M | ||
| Q3 25 | $2.8B | $718.4M | ||
| Q2 25 | $2.7B | $673.0M | ||
| Q1 25 | $2.5B | $596.3M | ||
| Q4 24 | $2.5B | $562.8M | ||
| Q3 24 | $2.5B | $616.3M | ||
| Q2 24 | $2.4B | $609.6M | ||
| Q1 24 | $2.3B | $621.4M |
| Q4 25 | $5.3B | $6.7B | ||
| Q3 25 | $5.1B | $5.3B | ||
| Q2 25 | $4.9B | $5.3B | ||
| Q1 25 | $4.5B | $5.1B | ||
| Q4 24 | $4.4B | $5.1B | ||
| Q3 24 | $4.6B | $5.3B | ||
| Q2 24 | $4.5B | $5.3B | ||
| Q1 24 | $4.4B | $5.4B |
| Q4 25 | 0.43× | 6.31× | ||
| Q3 25 | 0.20× | 3.61× | ||
| Q2 25 | 0.20× | 3.86× | ||
| Q1 25 | 0.22× | 4.38× | ||
| Q4 24 | 0.28× | 4.58× | ||
| Q3 24 | 0.32× | 4.28× | ||
| Q2 24 | 0.28× | 4.42× | ||
| Q1 24 | 0.29× | 4.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $120.5M |
| Free Cash FlowOCF − Capex | $96.9M | $54.7M |
| FCF MarginFCF / Revenue | 10.1% | 4.0% |
| Capex IntensityCapex / Revenue | 9.0% | 4.8% |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $155.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $120.5M | ||
| Q3 25 | $177.6M | $143.3M | ||
| Q2 25 | $126.0M | $91.9M | ||
| Q1 25 | $82.7M | $55.9M | ||
| Q4 24 | $178.2M | $151.2M | ||
| Q3 24 | $229.3M | $143.6M | ||
| Q2 24 | $143.6M | $142.8M | ||
| Q1 24 | $92.3M | $17.8M |
| Q4 25 | $96.9M | $54.7M | ||
| Q3 25 | $114.3M | $79.2M | ||
| Q2 25 | $62.5M | $34.6M | ||
| Q1 25 | $25.9M | $-13.4M | ||
| Q4 24 | $112.2M | $73.2M | ||
| Q3 24 | $162.7M | $70.4M | ||
| Q2 24 | $75.4M | $94.0M | ||
| Q1 24 | $16.7M | $-30.2M |
| Q4 25 | 10.1% | 4.0% | ||
| Q3 25 | 11.9% | 5.3% | ||
| Q2 25 | 6.5% | 2.3% | ||
| Q1 25 | 2.9% | -0.9% | ||
| Q4 24 | 13.2% | 5.3% | ||
| Q3 24 | 17.9% | 4.7% | ||
| Q2 24 | 8.3% | 5.8% | ||
| Q1 24 | 1.8% | -1.9% |
| Q4 25 | 9.0% | 4.8% | ||
| Q3 25 | 6.6% | 4.3% | ||
| Q2 25 | 6.6% | 3.7% | ||
| Q1 25 | 6.4% | 4.9% | ||
| Q4 24 | 7.8% | 5.6% | ||
| Q3 24 | 7.3% | 4.9% | ||
| Q2 24 | 7.5% | 3.0% | ||
| Q1 24 | 8.3% | 3.0% |
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | 15.58× | ||
| Q2 25 | 1.13× | 2.34× | ||
| Q1 25 | 1.05× | 7.87× | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | 14.36× | ||
| Q2 24 | 1.59× | 7.85× | ||
| Q1 24 | 1.11× | 0.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
